ISRCTN95766678已完成未知
Effect of a therapeutic strategy guided by lung ultrasound on 6-month outcomes in patients with heart failure. The EPICC trial
Sociedad Española de Medicina Interna0 个研究点目标入组 79 人开始时间: 2022年3月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 79
研究概览
简要总结
2019 Protocol article in https://doi.org/10.1007/s10557-019-06891-z (added 18/03/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36013168/ results (added 05/04/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age older than 18 y
- •2. NYHA functional class =II at inclusion
- •3. Able to attend ambulatory follow-up visits
排除标准
- •1. Life expectancy <6 months due to a different medical condition than HF
- •2. Heart transplantation
- •3. Acute coronary syndrome
- •4. Recent coronary revascularization
- •5. Valve replacement or resynchronization in the prior 3 months
- •6. Pregnancy
- •7. Restrictive pulmonary disease or severe COPD needing continuous oxygen
- •8. Serum creatinine >3 mg/dl or chronic renal insufficiency in dialysis
- •9. Severe valve stenosis
- •10. Participation in another randomized study
研究者
相似试验
招募中
不适用
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)Non-small Cell Lung CancerOligoprogressiveSmall-cell Lung CancerNCT06103682University of California, Davis100
Unknown
4 期
Goal Oriented Strategy to Preserve Ejection Fraction TrialPulmonary Arterial HypertensionNCT03236818Amsterdam UMC, location VUmc30
已完成
1 期
Innovative Pulmonary Solutions (IPS) System for Targeted Lung DenervationChronic Obstructive Pulmonary Disease (COPD)NCT01483534Nuvaira, Inc.22
已完成
不适用
A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery (ERAS) Protocols and Its Effects on Improving Post-Operative Lung FunctionColorectal SurgeryHepatobiliary SurgeryNCT04411186Medical University of South Carolina100
Unknown
2 期
Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar ProteinosisPulmonary Alveolar ProteinosisTreatmentNCT03316651Dai Huaping60
